Around half the products made at the Broomfield facility will be discontinued or divested says Novartis, blaming increased US generics competition and customer consolidation for the closure.
BioMoti and Pharmidex have received funding to advance proof-of-concept precision medicine studies – which if successful, could help secure pharma partnerships or additional investment, says BioMoti CEO.
The global contract development and manufacturing organization (CDMO) has launched its Almac Pod service solution in the US after introducing it in Europe last year.
The European Medicines Agency (EMA) has announced it will launch an updated version of information system EudraVigilance to better monitor suspected adverse reactions to medicines.
Cambrex Corporation has announced plans to start making high potency APIs at its plant in Milan, Italy citing impending patent losses for small molecule drugs as an opportunity.
Cambrex Corporation has announced a new investment in its research and development (R&D) and manufacturing capabilities at its site in Paullo, Milan, Italy.
Clinical study database challenges are delaying clinical trial timelines as CROs and sponsors must manage an increasing variety of trial data, according to a recent study.
ShangPharma Innovation and SRI International are collaborating to develop treatments for neurodegenerative and inflammatory conditions, such as Alzheimer’s disease.
Researchers are creating a “roadmap” for nephrology clinical trial design, which stresses the role patients and their families can play in rare disease study design.
Nestle Health Science has licensed a protein engineering platform from Codexis in a $14m deal that includes an option to co-develop a phenylketonuria drug candidate called CDX-6114.
The EDQM and Anvisa have signed an agreement that may allow drug firms seeking clearance to sell products in Brazil to file CEPs in approval applications.
China has announced that it will now accept clinical trial data from other countries in a new guideline that aims to reform the management of clinical trials.
BTS research has been recommended for AAALAC full accreditation at their new facility, which recently came under fire for reported violations of the federal Animal Welfare Act.
Gene therapy developers should start planning earlier, as EU GMO regulations are delaying clinical trial start-up across the bloc, according to a new expert position paper.
Depomed Inc. says supplies of the extended release version of Nucynta will be delayed as a result of damage to a Puerto Rico manufacturing plant caused by hurricane Maria.
CordenPharma will supply Pfizer with highly potent active pharmaceutical ingredients (HPAPIs) from the facility in Boulder once earmarked for closure by the Big Pharma firm.
The new Princeton, NJ-based office is the result of a multimillion-dollar investment and continued growth driven by an increasing use of medical imaging in clinical research.
Marken has acquired Touchdown International Ltd, a privately held specialty logistics company in Taiwan – a “key market” for pharma production and clinical trials.
CTTI has released new recommendations that can be implemented by sponsors, CROs, and others, in order to decrease the number of ‘one and done’ clinical trial site investigators.
Following the announced sale of AstraZeneca’s solid dose facility to Avara, the former outlines the Reims, France-based sites capabilities, and tells us why it is letting it go.
Antimalarial drug resistance in Southeast Asia is threatening the control and elimination of malaria, and drug makers can help, says a tropical medicine expert.
US-based medical device manufacturing plants could experience a 20% decrease in recalls if US FDA investigators inspect the facilities on a rotating schedule, according to a new study.
SynteractHCR has moved to a new 38,000 square foot facility in Carlsbad, CA as it looks to fill the mid-market CRO void created by recent consolidation, says CEO.
The EMA has expanded the list of excipients that drug firms must declare on product labels in a bid to address safety concerns about undeclared components.
Niche, small-scale CROs can stand their own – despite a predicted increase in consolidation among small-sized contract services firms – says Clinical Trial Consultants (CTC) and data-focused Quanticate.
Cullinan Oncology has launched with $150m in funding, a focus on risk, and a business model through which it will rely on a global network of third-party vendors, says CEO.
CMO PR agency ramarketing has secured investment to set up a US base in a bid to attract North American contractors interested in accessing the complex European market.
To simplify the human biospecimens procurement process, the online marketplace for outsourced scientific services, Scientist.com, has teamed up with iSpecimen.
Clinical trial participants often misunderstand the differences between research and clinical care – a ‘longstanding problem’ that an enhanced informed consent process could diminish, says report.
Merck KGaA will install a new aseptic filling line at its facility in Bari, Italy for multiple sclerosis drugs, fertility treatments and growth hormones.
Titan has teamed with Opiant to investigate skin implant technology in the administration of opioid antagonists over extended periods, to combat opioid relapse and overdose in outpatients.
Police investigating thousands of adverse events linked to Levothyrox, a reformulated version of the hypothyroidism pill Euthyrox, have visited Merck KGaA's production facility in Lyon, France.